Policy | September 26, 2023
India to launch National Policy on Research and Development and Innovation in Pharma-MedTech
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
To enable company to be future-ready by tapping potential in CDMO space
The partnership builds on a prior collaboration between Nimbus and Lilly targeting AMPK in cardiometabolic diseases
The privately held biotech brings a first-in-class oncology program focused on small molecule–targeted protein degradation
Sevabertinib is an oral, reversible tyrosine kinase inhibitor (TKI) that directly targets HER2 mutations
Cidara will become a wholly owned subsidiary of Merck and the common stock of Cidara will no longer be listed or traded on the Nasdaq Global Market
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
Subscribe To Our Newsletter & Stay Updated
